Assembly and regulation of the complement amplification loop in blood: The role of C3b-C3b-IgG complexes

Molecular Immunology

Volumn 36, Issue 13-14, 1999, Pages 837-842

  Jelezarova, Emiliana ^a   Lutz, Hans U ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

C3 convertase; Complement; Intravenous immunoglobulin; Properdin

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C4B; PROPERDIN;

ANIMAL CELL; BINDING SITE; COMPLEMENT ACTIVATION; COMPLEX FORMATION; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME INACTIVATION; GENE AMPLIFICATION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PURIFICATION; STEM CELL;

ANTIBODY FORMATION; COMPLEMENT ACTIVATION; COMPLEMENT C3-C5 CONVERTASES; COMPLEMENT C3B; COMPLEMENT FACTOR H; HUMANS; IMMUNOGLOBULIN G; MACROMOLECULAR SUBSTANCES; MODELS, BIOLOGICAL; OPSONIN PROTEINS; PROPERDIN;

EID: 0033379586     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(99)00104-2     Document Type: Conference Paper

References (43)

1. Arnaout M.A., Dana N., Melamed J., Medicus R., Colten H.R. Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor. Immunol. 48:1983;229-237.
2. Barrio E., Anton L.C., Marques G., Sanchez A., Vivanco F. Formation of covalently linked C3-C3 dimers on IgG immune aggregates. Eur. J. Biochem. 21:1991;343-349.
3. Basta M., Langlois P.F., Marques M., Frank M.M., Fries L.F. High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance. Blood. 74:1989;326-333.
4. Dempsey P.W., Allison M.E.D., Akkaraju S., Goodnow C.C., Fearon D.T. C3 d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science. 271:1996;348-350.
5. DiScipio R.D. The binding of human complement proteins C5, factor B, b1H and properdin to complement fragment C3b on zymosan. Biochem. J. 199:1981;485-496.
6. Fasler S., Skvaril F., Lutz H.U. Electrophoretic properties of human IgG and its subclasses on sodium dodecyl-sulfate-polyacrylamide gel electrophoresis and immunoblots. Analyt. Biochem. 174:1988;593-600.
7. Fries L.F., Gaither T.A., Hammer C.H., Frank M.M. C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I. J. Exp. Med. 160:1984;1640-1655.
8. Gadd K.J., Reid K.B.M. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum. Biochem. J. 195:1981;471-480.
9. Gadjeva M., Dodds A.W., Taniguchisidle A., Willis A.C., Isenman D.E., Law S.K.A. The covalent binding reaction of complement component C3. J. Immunol. 161:1998;985-990.
10. Harrison R.A., Lachmann P.J. The physiological breakdown of the third component of human complement. Mol. Immunol. 17:1980;9-20.
11. Jelezarova, E., Stammler, P., Späth, P.J., Lutz, H.U. (1999a). Complement activation generates predominantly C3b-C3b-IgG ester-linked between the 65 kDa fragments of the α′ C3 chains, (submitted for publication).
12. Jelezarova, E., Vogt, A., Lutz., (1999b). Interaction of C3b-C3b-IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification, (submitted for publication).
13. Junker A., Baatrup G., Svehag S.E., Wang P., Holmstrom E., Sturfelt G., Sjoholm A.G. Binding of properdin to solid-phase immune complexes: critical role of the classical activation pathway of complement. Scand. J. Immunol. 47:1998;481-486.
14. Kazatchkine M.D., Fearon D.T., Austen K.F. Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta 1H for cell-bound C3b. J. Immunol. 122:1979;75-81.
15. Kim Y.U., Carroll M.C., Isenman D.E., Nonaka M., Pramoonjago P., Takeda J., Inoue K., Kinoshita T. Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation. J. Biol. Chem. 267:1992;4171-4176.
16. Kinoshita T., Takata Y., Kozono H., Takeda J., Hong K., Inoue K. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme. J. Immunol. 141:1988;3895-3901.
17. Kinoshita T. Biology of complement: the overture. Immunol. Today. 12:1991;291-295.
18. Kirschfink M. Controlling the complement system in inflammation. Immunopharmacol. 38:1997;51-62.
19. Kulics J., Rajnavölgyi E., Füst G., Gergely J. Interaction of C3 and C3b with immunoglobulin G. Mol. Immunol. 20:1983;805-810.
20. Law S.K.A., Dodds A.W. The internal thioester and the covalent binding properties of the complement proteins C3 and C4. Protein Sci. 6:1997;263-274.
21. Lutz H.U., Stammler P., Fasler S. Preferential formation of C3b-IgG complexes in vitro and in vivo from nascent C3b and naturally occurring anti-band 3 antibodies. J. Biol. Chem. 268:1993;17,418-17,426.
22. n-IgG complexes. Blood. 88:1996;184-193.
23. Lutz H.U. How pre-existing, germline-derived antibodies and complement may help induce a primary immune response to nonself. Scand. J. Immunol. 49:1999;224-228.
24. Masaki T., Matsumoto M., Hara T., Nakanishi I., Kitamura H., Seya T. Covalently-bound human C4b dimers consisting of C4B isotype show higher hemolytic activity than those of C4A in the C3-bypass complement pathway. Mol. Immunol. 32:1995;21-26.
25. Meri S., Pangburn M.K. A mechanism of activation of the alternative complement pathway by classical pathway: protection of C3b from inactivation by covalent attachment to C4b. Eur. J. Immunol. 20:1990;2555-2561.
26. Mold C., Nemerow G.R., Bradt B.M., Cooper N.R. CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells. J. Immunol. 140:1988;1923-1929.
27. Mollnes T.E., Lachmann P.J. Regulation of complement. Scand. J. Immunol. 27:1988;127-142.
28. Müller-Eberhard H.J. Complement chemistry and pathways. Gallin J.I., Goldstein I.M., Snyderman R. Inflammation: Basic Principles and Clinical Correlates. 1992;33-61 Raven Press, New York.
29. Pangburn M.K. Analysis of recognition in the alternative pathway of complement. J. Immunol. 142:1989;2766-2770.
30. Pangburn M.K. Analysis of the mechanism of recognition in the complement alternative pathway using C3b-bound low molecular weight polysaccharides. J. Immunol. 142:1989;2759-2765.
31. Rawal N., Pangburn M.K. C5 convertase of the alternative pathway of complement. Kinetic analysis of the free and surface-bound forms of the enzyme. J. Biol. Chem. 273:1998;16,828-16,835.
32. Sahu A., Kozel T.R., Pangburn M.K. Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation. Biochem. J. 302:1994;429-436.
33. Sahu A., Pangburn M.K. Covalent attachment of human complement C3 to IgG. Identification of the amino acid residue involved in ester linkage formation. J. Biol. Chem. 269:1994;28,997-29,002.
34. Schwendinger M.G., Spruth M., Schoch J., Dierich M.P., Prodinger W.M. A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cells. J. Immunol. 158:1997;5455-5463.
35. Sengelov H. Complement receptors in neutrophils. Crit. Rev. Immunol. 15:1995;107-131.
36. Sharma A.K., Pangburn M.K. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc. Natl. Acad. Sci. USA. 93:1996;10,996-11,001.
37. Shohet J.M., Bergamaschini L., Davis A.E., Carroll M.C. Localization of the human complement component C3 binding site on the IgG heavy chain. J. Biol. Chem. 266:1991;18,520-18,524.
38. Takata Y., Tamura N., Fujita T. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates. J. Immunol. 132:1984;2531-2537.
39. Takata Y., Kinoshita T., Kozono H., Takeda E., Hong K., Inoue K. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway. J. Exp. Med. 165:1987;1494-1500.
40. Thornton B.P., Vetvicka V., Ross G.D. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J. Immunol. 152:1994;1727-1737.
41. Vogt W., Schmidt G., Von Buttlar B., Dieminger L. A new function of the activated third component of complement: binding to C5, an essential step for C5 activation. Immunol. 34:1978;29-40.
42. Volanakis J.E. C3 convertases of complement. Cruse J.M., Lewis R.E. The Year in Immunology. 1988;218-230 Karger, Basel.
43. Whiteman L.Y., Purkall D.B., Ruddy S. Association of activated properdin with complexes of properdin with C3. J. Immunol. 147:1991;1344-1351.